Reduction of plasma high-density lipoprotein2 cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment
- 1 August 1981
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 115 (1), 63-71
- https://doi.org/10.1016/0009-8981(81)90107-8
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in manAtherosclerosis, 1980
- Demonstration of a heparin‐releasable liver‐lipase‐like activity in rat adrenalsFEBS Letters, 1980
- Hepatic endothelial lipase antiserum influences rat plasma low and high density lipoproteins in vivoFEBS Letters, 1979
- Plasma Lipids and High Density Lipoproteins during Oral Contraception with Different Combinations of Ethinyl Estradiol and LevonorgestrelHormone and Metabolic Research, 1979
- NATURAL ŒSTROGEN AS AN EFFECTIVE TREATMENT FOR TYPE-II HYPERLIPOPROTEINÆMIA IN POSTMENOPAUSAL WOMENThe Lancet, 1978
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase.Journal of Clinical Investigation, 1977
- Effect of chronic administration of propranolol on lipoprotein compositionMetabolism, 1976
- An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- Ischemic Heart Disease, Atherosclerosis, and LongevityCirculation, 1966